Aspirin: Nursing Drug Guide, GI Bleeding & NCLEX Review
Healthcare medication guide: antiplatelet and NSAID bleeding risk, GI ulcer precautions, duplicate NSAID stacking, Reye syndrome prevention in pediatrics, and same-day bleeding escalation for one of the most common OTC and cardioprotective drugs.
Aspirin is an NSAID that can cause severe stomach bleeding, especially with anticoagulants, steroids, other NSAIDs, age 60 or older, prior ulcer or bleeding history, daily alcohol use, or doses above label directions. Antiplatelet aspirin also increases bleeding risk during surgery, trauma, and stroke care. Children and teenagers with chickenpox or flu-like illness must not receive aspirin because of Reye syndrome risk. Nurses must reconcile all aspirin sources (scheduled low-dose, PRN analgesic, combination products), verify allergy and bleeding cues before every dose, and escalate immediately for hematemesis, melena, hypotension, or neurologic change.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Before every dose, confirm allergy status, active bleeding signs, duplicate NSAID or anticoagulant therapy, and whether the patient is a child or teen with viral illness. Aspirin that looks routine on the MAR can trigger severe GI hemorrhage or Reye syndrome when risk factors are missed.
Most common brand names
Aspirin (acetylsalicylic acid) appears as immediate-release and enteric-coated tablets, low-dose cardioprotective products, and combination OTC formulations. Always verify strength (81 mg vs 325 mg) and formulation on the MAR—not just the brand name.
Common brands include Bayer Genuine Aspirin, Ecotrin (enteric-coated), and store-label 325 mg tablets. Low-dose products (often 81 mg) are widely used for antiplatelet therapy when ordered by a prescriber. Combination products may pair aspirin with caffeine or other analgesics; duplicate NSAID therapy with ibuprofen or other salicylates increases bleeding risk per OTC labeling.
Why we give it — Indications
Aspirin is used for analgesia, antipyresis, and—at low daily doses—as antiplatelet therapy when prescribed for cardiovascular risk reduction. Nurses must match the indication to the ordered strength and frequency.
| Use | Detail |
|---|---|
| Pain and fever (OTC) | OTC Drug Facts label temporary relief of minor aches and pains (headache, muscle pain, toothache, menstrual pain, colds, minor pain of arthritis) and temporary fever reduction. Not for children under 12 years without clinician direction per label. |
| Cardioprotection (prescriber-directed) | Low-dose aspirin (commonly 81 mg daily) is frequently ordered after heart attack or for stroke prevention per institutional protocol and prescriber order. Dose and duration for secondary prevention are not specified in the reviewed OTC 325 mg Drug Facts—verify cardiovascular orders and current guidelines. |
| Other uses | Additional prescription indications (e.g., Kawasaki disease, specific rheumatic disorders) are not specified in the reviewed OTC prescribing information. Follow prescriber orders and specialist guidance when aspirin is used outside OTC labeling. |
On a small screen, swipe or scroll sideways to see the full table.
How it works
Aspirin (acetylsalicylic acid) irreversibly inhibits cyclooxygenase (COX), decreasing prostaglandin synthesis. That reduces pain, fever, and inflammation, but also diminishes protective gastric prostaglandins—raising GI mucosal injury risk. At low doses, aspirin preferentially inhibits platelet COX-1, reducing thromboxane A2 and platelet aggregation for the platelet lifespan (~7–10 days). This antiplatelet effect underlies both cardioprotective benefit and bleeding complications. Nurses should expect prolonged bleeding time after doses and coordinate perioperative hold rules per protocol.
Dosing overview
Dosing depends on indication (analgesia vs antiplatelet), formulation (immediate-release vs delayed-release), and prescriber order. The critical nursing rule: track all aspirin and NSAID sources and do not exceed OTC maximums unless explicitly directed by a clinician.
Missed dose: Not specified in the reviewed prescribing information. For scheduled low-dose aspirin, follow prescriber and institutional protocol—do not double doses without clarification.
Before you give it — Safety check
Pretreatment checks
- Confirm allergy to aspirin or other pain relievers/fever reducers; review prior reactions (hives, facial swelling, wheezing, shock per label)
- Screen for GI bleeding risk: age 60+, prior ulcer or bleeding, peptic ulcer history, anticoagulant or steroid use, concurrent NSAIDs, daily alcohol
- Reconcile all aspirin/NSAID sources (scheduled 81 mg, PRN 325 mg, combination products, home OTC) via medication reconciliation
- Verify age and viral illness status in pediatrics—no aspirin in chickenpox or flu-like illness (Reye syndrome warning)
- Check upcoming surgery or procedures; confirm perioperative hold per protocol when antiplatelet aspirin is ordered
Contraindications / do not use
- Allergy to aspirin or any other pain reliever/fever reducer, or prior allergic reaction to this product or ingredients (OTC Drug Facts)
- Children and teenagers with or recovering from chickenpox or flu-like symptoms (Reye syndrome warning)
- Not specified in the reviewed prescribing information as an absolute contraindication for all adults with cardiovascular disease—use prescriber judgment for benefit vs bleeding risk
Important interactions
| Drug / class | Effect | Nursing action |
|---|---|---|
| Warfarin / anticoagulants | OTC labeling: stomach bleeding risk higher with blood thinning (anticoagulant) drugs; additive bleeding with antiplatelet effect | Monitor INR and bleeding signs per protocol; hold and notify for hematuria, melena, or bruising |
| Other NSAIDs (ibuprofen, naproxen, additional aspirin) | Increased severe stomach bleeding risk per stomach bleeding warning | Hold duplicate NSAID doses; clarify analgesic plan with pharmacist |
| Corticosteroids | Increased GI bleeding risk when combined with NSAID per label | Assess GI symptoms; escalate black stools or hematemesis |
| Alcohol (≥3 drinks/day) | Higher chance of severe stomach bleeding per label | Document alcohol use; reinforce avoidance with alcohol use disorder history |
On a small screen, swipe or scroll sideways to see the full table.
Administration
Route: Oral tablets (immediate-release and enteric-coated/delayed-release). Follow medication administration rights and swallowing assessment when needed.
- Give with a full glass of water per OTC directions
- Confirm tablet strength (81 mg vs 325 mg) matches the order before scanning and administering
- Enteric-coated/delayed-release products will not provide fast relief of headache or acute symptoms needing immediate effect per delayed-release labeling
- Do not crush enteric-coated products unless pharmacy approves an alternate formulation—Not specified in the reviewed prescribing information for all brands
Low-dose daily aspirin orders are often time-sensitive after acute coronary events. If a dose is held for bleeding concerns or procedure, document the hold, notify the prescriber, and clarify restart timing per institutional protocol.
Expected therapeutic response
- Improved pain or fever after PRN analgesic doses when reassessed with pain assessment and temperature trends
- For antiplatelet therapy: no immediate symptom change—benefit is thrombosis prevention; continue monitoring for bleeding instead of pain relief
- Absence of new GI pain, melena, hematemesis, dizziness, or tachycardia suggesting occult hemorrhage
Red flags — Stop and act
GI bleeding and salicylate toxicity can escalate quickly. Stop aspirin and escalate when any of the following occur.
- Signs of stomach bleeding per label: feel faint, vomit blood, bloody or black stools, or stomach pain that does not improve
- Easy bruising, petechiae, or uncontrolled bleeding in patients on aspirin plus anticoagulant therapy
- Severe allergic reaction: hives, facial swelling, wheezing, or shock—seek emergency care per allergy alert
- Child or teen with nausea, vomiting, and behavior changes after aspirin during viral illness (possible Reye syndrome)
- Ringing in ears, hearing loss, deep rapid breathing, confusion, or fever after large ingestion (possible salicylate toxicity)—contact poison control per facility protocol
- Pain worsens or lasts more than 10 days, or fever worsens or lasts more than 3 days per stop-use labeling
Adverse effects
| Adverse effect | Frequency / severity | Nursing response |
|---|---|---|
| GI irritation / dyspepsia | Common with NSAIDs; not quantified in reviewed OTC Drug Facts | Assess for heartburn history; escalate persistent epigastric pain |
| Severe stomach bleeding / ulceration | Serious; risk increases with age, ulcers, anticoagulants, steroids, other NSAIDs, alcohol | Hold aspirin, notify prescriber, monitor hemoglobin and hemodynamic status, prepare for GI evaluation |
| Bleeding (prolonged) | Expected pharmacologic effect at antiplatelet doses | Monitor bruising, bleeding gums, hematuria; coordinate perioperative holds |
| Hypersensitivity / anaphylaxis | Severe allergic reaction may include hives, facial swelling, wheezing, shock per label | Stop drug permanently; emergency treatment per protocol |
| Tinnitus / hearing loss | Listed in stop-use directions when ringing or hearing loss occurs | Hold drug; assess for salicylate toxicity if high dose exposure |
| Reye syndrome (pediatrics) | Rare but serious with aspirin in viral illness per label | Never administer to children/teens with chickenpox or flu-like symptoms; educate caregivers |
On a small screen, swipe or scroll sideways to see the full table.
Specific adverse event incidence rates are not specified in the reviewed OTC prescribing information.
Overdose, toxicity, and antidote
Salicylate overdose (acute or chronic) can cause serious acid-base disturbances, tinnitus, hyperventilation, altered mental status, seizures, and death. OTC labeling directs immediate medical help for overdose.
Early signs
- Nausea, vomiting, tinnitus, dizziness, confusion
- Hyperpnea or deep rapid breathing, fever, dehydration
- Not specified in the reviewed OTC Drug Facts as a complete early-sign list—follow toxicology protocol when ingestion is suspected
Antidote
Not specified in the reviewed prescribing information as a single labeled antidote for aspirin overdose. Management typically includes supportive care, serial salicylate levels, electrolyte and acid-base correction, and urinary alkalinization when indicated per poison control or medical toxicology guidance.
Contact local poison control or medical toxicology services immediately for suspected salicylate overdose per facility protocol and local emergency guidance. Do not wait for symptoms to worsen.
Look-alike / sound-alike and error prevention
- Aspirin vs acetaminophen (Tylenol)—patients often say “aspirin” for any pain pill; verify active ingredient before administration
- 81 mg vs 325 mg—low-dose cardioprotective tablets look similar to analgesic strength; independent double-check high-risk patients
- ASA abbreviation—can be confused with other abbreviations; use full drug name in teaching and documentation when feasible
- Enteric-coated vs plain aspirin—wrong formulation may be given when prescriber expects immediate release for acute pain
- Duplicate NSAID therapy—patient on aspirin plus ibuprofen PRN is a common outpatient and inpatient stacking error
- Buffered or combination products—verify whether caffeine or other analgesics are present before adding another NSAID
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Crush/split | Do not crush enteric-coated aspirin without pharmacy approval; Not specified in the reviewed prescribing information for all brands. |
| Food timing | Take with food or milk if GI upset occurs—Not specified in the reviewed OTC Drug Facts as mandatory; follow patient tolerance and protocol. |
| Perioperative hold | Many protocols hold antiplatelet aspirin before elective surgery; confirm timing with prescriber and anesthesia. |
| Storage | Store at room temperature per OTC labeling; protect from excess heat and moisture. |
| Lab timing | For bleeding: trend hemoglobin/hematocrit; for overdose: salicylate level and blood gas per toxicology protocol—not specified in OTC label. |
| Commonly missed | Home 81 mg plus inpatient PRN 325 mg, plus ibuprofen, plus anticoagulant without documented bleeding plan. |
| Ask pharmacy when | Duplicate NSAID orders, unclear strength, perioperative restart questions, or suspected salicylate toxicity. |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Adults 60 years and older | OTC stomach bleeding warning lists age 60 or older as a higher-risk factor. Use lowest effective dose for shortest duration and monitor for GI bleeding and falls with dizziness. |
| Prior GI ulcer or bleeding | History of stomach problems, heartburn, or prior ulcer disease increases severe bleeding risk per label—coordinate gastroprotection per prescriber. |
| Anticoagulant / antiplatelet polypharmacy | Concurrent warfarin, other antiplatelet agents, or procedure-related bleeding requires heightened surveillance and hold rules. |
| Children and teenagers | Do not use with chickenpox or flu-like illness (Reye syndrome). Children under 12 years: ask a doctor per OTC directions. |
| Pregnancy | OTC labeling: ask a health professional before use; especially important not to use during the last 3 months of pregnancy unless directed by a doctor because it may cause problems in the unborn child or complications during delivery. |
| Lactation | LactMed (updated June 2025): with low-dose aspirin (75–325 mg daily), no aspirin is excreted into breastmilk and salicylate levels are low; monitor infant for bruising and bleeding. Continuous high-dose aspirin is not preferred. |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- GI status: epigastric pain, nausea, hematemesis, melena, or blood in stool
- Bleeding: bruising, gum bleeding, hematuria, dropping hemoglobin on complete blood count
- Vitals: orthostatic blood pressure, heart rate, and signs of hypovolemia if GI bleed suspected
- Coagulation studies and bleeding assessment when aspirin is combined with anticoagulants per protocol
- Pain/fever response when used as analgesic; tinnitus or confusion if high-dose exposure
Document
- Strength (81 mg vs 325 mg), dose, route, time, indication, and any hold/restart for procedures
- Reconciled NSAID and anticoagulant list; patient-reported home aspirin and alcohol use
- Education on bleeding signs, avoiding duplicate NSAIDs, pediatric Reye risk, and local poison control/toxicology access for overdose
Patient teaching
- Take only as directed; do not exceed 12 tablets (325 mg) in 24 hours unless your clinician directs otherwise; drink a full glass of water with each dose
- Do not combine with other NSAIDs (ibuprofen, naproxen, extra aspirin) unless your prescriber approves—severe stomach bleeding risk
- Report immediately: vomiting blood, black stools, severe stomach pain, dizziness, or unusual bruising
- Limit alcohol; three or more alcoholic drinks daily increases bleeding risk per label
- Never give aspirin to children or teens with chickenpox or flu-like illness; ask a clinician before pediatric use
- For overdose, seek emergency care and contact local poison control or toxicology services per facility guidance—do not wait for symptoms
The Hold Rule
Do not give and contact the prescriber/pharmacist when:
- Known aspirin or NSAID allergy, or active allergic reaction (hives, facial swelling, wheezing, shock)
- Active GI bleeding signs: hematemesis, melena, persistent epigastric pain, or hemodynamic instability
- Child or teenager with chickenpox, influenza, or flu-like illness (Reye syndrome risk)
- Duplicate NSAID or anticoagulant therapy without prescriber approval; PRN dose would exceed OTC 24-hour maximum
- Perioperative or pre-procedure hold window per protocol unless prescriber explicitly orders continuation
- Suspected salicylate overdose or new tinnitus, confusion, or deep rapid breathing after high exposure
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Aspirin is everywhere—81 mg on the MAR, 325 mg PRN in the drawer, and ibuprofen at home. Bleeding risk is cumulative across products and comorbidities, not just the tablet you are holding.
1. Check-before-you-give protocol
- Right patient, right drug, right dose (81 vs 325 mg), right route, right time—and right bleeding risk profile
- Confirm no pediatric viral illness contraindication and no active GI bleed symptoms
- Reconcile NSAIDs and anticoagulants on MAR and home med list before every PRN dose
- Verify perioperative hold/restart orders when aspirin is prescribed for cardioprotection
2. High-alert and safety badge
Routine OTC appearance; bleeding and Reye risks require safety checksAlthough not universally classified as a high-alert medication, aspirin antiplatelet effects and NSAID GI toxicity warrant independent double-check of strength and duplicate therapy—especially after acute coronary admission or before procedures.
3. Clinical workflow: hold and question rules
- If the patient reports dark stools or coffee-ground emesis, hold aspirin and activate GI bleeding pathway before the next scheduled dose
- If ibuprofen PRN is requested while on daily aspirin, contact pharmacy—duplicate NSAID may be contraindicated per label warnings
- For suspected salicylate overdose, contact poison control or toxicology immediately—do not wait for tinnitus or lab confirmation to escalate
4. Critical teach-back questions
- “What bleeding symptoms should you report right away?” (Patient should name vomiting blood, black stools, severe stomach pain, dizziness, or unusual bruising.)
- “Can you take ibuprofen or extra aspirin while on this medicine?” (Patient should say no unless the prescriber approves, because of severe stomach bleeding risk.)
5. Care coordination
Pharmacist: Consult for duplicate NSAID therapy, perioperative hold/restart, anticoagulant overlap, and salicylate toxicity management
Prescriber / gastroenterology: Notify for GI bleeding, refractory dyspepsia on aspirin, or need for gastroprotective strategy
🧠 Quick mental checklist
- Is this 81 mg or 325 mg, and does the order match the indication?
- Any GI bleeding signs, anticoagulant use, other NSAIDs, or daily alcohol?
- Is the patient a child/teen with viral illness (Reye risk)?
- Is surgery or a procedure planned—should aspirin be held?
- If overdose suspected, has poison control or toxicology been contacted?
Aspirin NCLEX practice questions
Practice NCLEX-style clinical judgment practice for aspirin using a tabbed case (MAR, labs, vitals, nursing notes), then priority action, bleeding cue recognition, trend interpretation, documentation cloze, and matrix urgency—recognise cues → analyse → prioritise → act → evaluate outcomes.
Select a tab to view MAR, labs, vitals, and nursing note details for this case.
- Aspirin 81 mg PO daily scheduled — given 0800
- Aspirin 325 mg PO q4h PRN mild pain — 1 tablet at 1200
- Ibuprofen 400 mg PO q6h PRN pain — not given
- Warfarin 5 mg PO daily — held this morning per protocol; INR due 1400
- 1400: patient requests ibuprofen for chest wall pain 6/10
- Admission: Hgb 13.8 g/dL, Hct 41%, platelets 210 ×109/L, INR 2.4 on warfarin
- 1200 (post-PRN aspirin): Hgb 13.4 g/dL; stool guaiac pending
- 1400: repeat Hgb 12.6 g/dL; INR 2.6
- 0800: BP 128/72, HR 78, RR 16, SpO2 97% on room air
- 1330: BP 98/58, HR 108, patient reports dizziness when sitting up
- Urine output 40 mL/hr; no emesis documented
- 72-year-old, day 2 after NSTEMI; history of peptic ulcer disease
- 1330: Patient reports dark, tarry stool ×1; mild epigastric discomfort; denies hematemesis
- 1345: Nurse held 1400 aspirin and notified charge nurse; awaiting prescriber callback
Answer key & rationale
Frequently asked questions
When should a nurse hold aspirin?
Hold aspirin and contact the prescriber or pharmacist for known aspirin or NSAID allergy, active GI bleeding signs (vomit blood, bloody or black stools, persistent stomach pain), suspected salicylate overdose, scheduled surgery or invasive procedures per protocol, children or teenagers with chickenpox or flu-like illness (Reye syndrome risk), or when duplicate NSAID therapy would exceed label limits. Hold if the patient takes anticoagulants or other NSAIDs without prescriber clearance.
What is the maximum OTC aspirin dose for adults?
OTC Drug Facts for aspirin 325 mg tablets direct adults and children 12 years and over to take 1 to 2 tablets every 4 hours or 3 tablets every 6 hours, not to exceed 12 tablets in 24 hours unless directed by a doctor. Drink a full glass of water with each dose.
What antidote is used for aspirin overdose?
The reviewed OTC Drug Facts do not list a single labeled antidote for aspirin overdose. Management is supportive and guided by poison control or medical toxicology per facility protocol, including salicylate level monitoring and alkalinization when indicated. Contact local poison control or toxicology services immediately for suspected overdose.
Can aspirin cause serious stomach bleeding?
Yes. OTC labeling warns that aspirin is an NSAID that may cause severe stomach bleeding, with higher risk in adults 60 or older, prior ulcer or bleeding history, concurrent anticoagulant or steroid use, other NSAIDs, three or more alcoholic drinks daily, or use longer than directed.
Is low-dose aspirin safe during breastfeeding?
LactMed states that with low-dose aspirin (75 to 325 mg daily), no aspirin is excreted into breastmilk and salicylate levels are low. If a nursing mother uses aspirin, monitor the infant for bruising and bleeding. Continuous high-dose aspirin therapy is not preferred during breastfeeding.
Why must nurses avoid giving aspirin to children with viral illness?
OTC labeling warns that children and teenagers with or recovering from chickenpox or flu-like symptoms should not use aspirin because nausea and vomiting with behavior changes may signal Reye syndrome, a rare but serious illness.
References
-
U.S. National Library of Medicine. ASPIRIN REGULAR STRENGTH (aspirin 325 mg) tablet — OTC Drug Facts. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26942d32-d6e6-464d-8fc4-ffd9806d3e62
-
U.S. National Library of Medicine. BAYER GENUINE ASPIRIN (aspirin) tablet — OTC Drug Facts. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23daa359-d40f-4f64-81be-6d154f41df9f
-
Drugs and Lactation Database (LactMed). Aspirin. Bethesda (MD): National Institute of Child Health and Human Development; updated June 15, 2025.https://www.ncbi.nlm.nih.gov/books/NBK501196/
-
U.S. National Library of Medicine. Aspirin — MedlinePlus consumer information.https://medlineplus.gov/druginfo/meds/a682878.html
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.